EGM
TRAW icon

Engineers Gate Manager’s Traws Pharma TRAW Stock Holding History

Engineers Gate Manager’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-424
Closed -$41K – 2338
2021
Q3 		$41K Buy
+424
New +$54.6K ﹤0.01% 1578

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Engineers Gate Manager's TRAW Position: Q4 2021 in Review

Engineers Gate Manager sold out of Traws Pharma (TRAW) in Q4 2021, closing a stake of 424 shares — an estimated $41K sold.

Engineers Gate Manager first reported a position in TRAW in Q3 2021 and held it in 1 quarter. The position peaked at $41K in Q3 2021. 34 funds tracked by Wall St. Rank hold TRAW as of Q4 2021.

  • Engineers Gate Manager reported no remaining Traws Pharma position as of Q4 2021 after selling out during the quarter.
  • Engineers Gate Manager sold 424 Traws Pharma shares in Q4 2021, an estimated $41K.
  • Engineers Gate Manager first reported a position in Traws Pharma in Q3 2021 and held it in 1 quarter.
  • Engineers Gate Manager's Traws Pharma position peaked at $41K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Traws Pharma as of Q4 2021.

Based on Engineers Gate Manager's 13F filing for Q4 2021, filed 14 Feb 2022.